SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-24-187843
Filing Date
2024-07-29
Accepted
2024-07-29 19:24:49
Documents
2
Group Members
ARTAL GROUP S.A.ARTAL INTERNATIONAL MANAGEMENT S.A.ARTAL INTERNATIONAL S.C.A.INVUS PUBLIC EQUITIES ADVISORS, LLCINVUS PUBLIC EQUITIES, L.P.MR. AMAURY WITTOUCKRAYMOND DEBBANESIREN, L.L.C.STICHTING ADMINISTRATIEKANTOOR WESTENDWESTEND S.A.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d810309dsc13ga.htm SC 13G/A 176575
2 EX-99.1 d810309dex991.htm EX-99.1 12601
  Complete submission text file 0001193125-24-187843.txt   191198
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Subject) CIK: 0001253689 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87811 | Film No.: 241154017
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address THE INVUS GROUP, LLC 750 LEXINGTON AVENUE, 30TH FLOOR NEW YORK NY 10022
Business Address THE INVUS GROUP, LLC 750 LEXINGTON AVENUE, 30TH FLOOR NEW YORK NY 10022 212-371-1717
Invus Global Management, LLC (Filed by) CIK: 0002005369 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A